The Claim
In adults with upper-body obesity and/or type 2 diabetes, the extent of insulin-mediated suppression of free fatty acid release from adipose tissue is strongly associated with the extent of niacin-mediated suppression of free fatty acid release from adipose tissue.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with upper-body obesity or type 2 diabetes, the degree to which insulin reduces free fatty acid release from fat tissue is closely related to the degree to which niacin reduces the same release.
See the scientific wording
In adults with upper-body obesity and/or type 2 diabetes, the degree to which insulin suppresses free fatty acid release from adipose tissue is strongly associated with the degree to which niacin suppresses the same process, suggesting a shared downstream regulation of lipolysis despite distinct upstream signaling pathways.
In people with upper-body obesity or type 2 diabetes, fat cells cannot properly shut down fat breakdown no matter whether the signal comes from insulin or niacin, because the final control points that stop fat release are broken, even though the signals start differently.
What the research says
1 studyStudy: Adipose Tissue Resistance to the Antilipolytic Effect of Insulin and Niacin in Humans With Obesity.
In people with obesity or type 2 diabetes, how well insulin slows fat breakdown is very closely linked to how well niacin does the same—even though they work differently at first. This suggests both drugs hit the same final brake on fat release, even if they start from different places.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.